These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16118374)

  • 1. Could a novel vaccine help smokers quit?
    Kuehn BM
    JAMA; 2005 Aug; 294(8):891-2. PubMed ID: 16118374
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic vaccines for nicotine dependence.
    Maurer P; Bachmann MF
    Curr Opin Mol Ther; 2006 Feb; 8(1):11-6. PubMed ID: 16506520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expecting the antinicotine vaccine].
    Didilescu C
    Pneumologia; 2009; 58(3):177-8. PubMed ID: 19817315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.
    Hatsukami DK; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR
    Clin Pharmacol Ther; 2005 Nov; 78(5):456-67. PubMed ID: 16321612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine conjugate vaccines: A novel approach in smoking cessation.
    Kitchens CM; Foster SL
    J Am Pharm Assoc (2003); 2012; 52(1):116-8. PubMed ID: 22257625
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune to nicotine addiction?].
    Schumacher B
    MMW Fortschr Med; 2013 Mar; 155(5):22-3. PubMed ID: 23654124
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotine-Targeting Nano-Vaccines for Smoking Cessation.
    Desai RI; Bergman J
    Neuropsychopharmacology; 2016 Jan; 41(1):377-8. PubMed ID: 26657956
    [No Abstract]   [Full Text] [Related]  

  • 8. A shot at quitting.
    Smith SD
    Minn Med; 2006 Sep; 89(9):9-10. PubMed ID: 17024915
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent progress in vaccines against nicotine addiction].
    Wang GB; Zhu CJ
    Yao Xue Xue Bao; 2013 Aug; 48(8):1189-94. PubMed ID: 24187824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine conjugate vaccine as a novel approach to smoking cessation.
    Ottney AR
    Pharmacotherapy; 2011 Jul; 31(7):703-13. PubMed ID: 21923458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The vaccine against nicotine--the future for smoking cessation?].
    Mihăltan F
    Pneumologia; 2007; 56(2):101-3. PubMed ID: 18019757
    [No Abstract]   [Full Text] [Related]  

  • 12. Why a nicotine vaccine?
    Le Houezec J
    Clin Pharmacol Ther; 2005 Nov; 78(5):453-5. PubMed ID: 16321611
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-nicotine abuse vaccines in the pipeline: an update.
    Cerny EH; Cerny T
    Expert Opin Investig Drugs; 2008 May; 17(5):691-6. PubMed ID: 18447595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical evaluation of a nicotine vaccine within a self-administration behavioral model.
    Moreno AY; Azar MR; Warren NA; Dickerson TJ; Koob GF; Janda KD
    Mol Pharm; 2010 Apr; 7(2):431-41. PubMed ID: 20104903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New prospects of nicotine dependence treatment--vaccines].
    Goniewicz ML; Koszowski B; Czogała J; Zymełka A
    Przegl Lek; 2006; 63(10):1114-8. PubMed ID: 17288232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of bupropion for smoking cessation during pregnancy.
    Chan B; Einarson A; Koren G
    J Addict Dis; 2005; 24(2):19-23. PubMed ID: 15784520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.
    LeSage MG; Keyler DE; Pentel PR
    AAPS J; 2006 Feb; 8(1):E65-75. PubMed ID: 16584135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the protective effects of a conformationally constrained nicotine vaccine.
    Moreno AY; Azar MR; Koob GF; Janda KD
    Vaccine; 2012 Oct; 30(47):6665-70. PubMed ID: 22963803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.
    Rosenberg JB; De BP; Hicks MJ; Janda KD; Kaminsky SM; Worgall S; Crystal RG
    Hum Gene Ther; 2013 Jun; 24(6):595-603. PubMed ID: 23611296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.
    Hatsukami DK; Jorenby DE; Gonzales D; Rigotti NA; Glover ED; Oncken CA; Tashkin DP; Reus VI; Akhavain RC; Fahim RE; Kessler PD; Niknian M; Kalnik MW; Rennard SI
    Clin Pharmacol Ther; 2011 Mar; 89(3):392-9. PubMed ID: 21270788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.